STOCK TITAN

Bradley Campbell sells 75,000 FOLD shares under 10b5-1 plan (FOLD)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Bradley Campbell reported sales of Common stock under 10b5-1 plans. The filing lists executed sales of 75,000 shares on 01/20/2026 for $1,073,182.50, 70,426 shares on 12/15/2025 for $763,509.39, and 7,500 shares on 12/15/2025 for $82,500.00.

The broker listed is Morgan Stanley Smith Barney LLC. The filing also shows 22,500 Restricted and Performance Stock Units dated 01/03/2021 as securities to be sold.

Positive

  • None.

Negative

  • None.

Insights

Insider reported multiple planned sales under 10b5-1, with material share amounts in December 2025 and January 2026.

The filing documents three executed 10b5-1 transactions: 75,000 shares on 01/20/2026 for $1,073,182.50, and two transactions on 12/15/2025 totaling 77,926 shares for $845, + $763,509.39. These are reported dispositions by the reporting person.

Timing and pricing reflect plan execution; cash‑flow treatment is the proceeds to the selling holder. Subsequent filings may show additional dispositions or amended plan details.

10b5-1 activity is routine for planned insider sales; the broker is Morgan Stanley Smith Barney LLC.

The excerpt also lists 22,500 Restricted and Performance Stock Units dated 01/03/2021 as securities to be sold. The RSUs are shown with an issuer designation and the date provided.

Observe future filings for any additional reported sales or amendments to the 10b5-1 plans that would change disclosed volumes or dates.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Bradley Campbell report in the Form 144 for FOLD?

Bradley Campbell reported multiple 10b5-1 sales of Common stock, including 75,000 shares on 01/20/2026 for $1,073,182.50. The filing also lists 70,426 shares and 7,500 shares sold on 12/15/2025 for stated proceeds.

Who acted as broker for the reported sales in the FOLD filing?

The broker listed is Morgan Stanley Smith Barney LLC at 1 New York Plaza, 8th Floor, New York, NY. That broker is associated with the transactions disclosed in the filing.

How many Restricted and Performance Stock Units are listed to be sold?

The filing shows 22,500 Restricted and Performance Stock Units dated 01/03/2021 as securities to be sold. The entry identifies these units and their grant date.

What proceeds were reported for the December 15, 2025 sales?

Two sales on 12/15/2025 are reported: 70,426 shares for $763,509.39 and 7,500 shares for $82,500.00, as shown in the filing’s transaction rows.

Does the Form 144 indicate who receives the sale proceeds?

The filing lists the selling individual and broker; it shows dollar proceeds for each transaction, which are proceeds to the selling holder. The document does not state company receipt of proceeds.
Amicus Therapeut

NASDAQ:FOLD

View FOLD Stock Overview

FOLD Rankings

FOLD Latest News

FOLD Latest SEC Filings

FOLD Stock Data

4.51B
303.37M
Biotechnology
Pharmaceutical Preparations
Link
United States
PRINCETON